Cargando…

Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy

Galactose-deficient IgA1 (Gd-IgA1) and IgA-IgG complexes are known to play an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed therefore to determine the impact of immunosuppression on the serum levels of Gd-IgA1, total IgA1 and IgA-IgG complexes in IgAN patients. In a retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Min Jeong, Schaub, Stefan, Molyneux, Karen, Koller, Michael T., Stampf, Susanne, Barratt, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145158/
https://www.ncbi.nlm.nih.gov/pubmed/27930655
http://dx.doi.org/10.1371/journal.pone.0166830
_version_ 1782473245682827264
author Kim, Min Jeong
Schaub, Stefan
Molyneux, Karen
Koller, Michael T.
Stampf, Susanne
Barratt, Jonathan
author_facet Kim, Min Jeong
Schaub, Stefan
Molyneux, Karen
Koller, Michael T.
Stampf, Susanne
Barratt, Jonathan
author_sort Kim, Min Jeong
collection PubMed
description Galactose-deficient IgA1 (Gd-IgA1) and IgA-IgG complexes are known to play an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed therefore to determine the impact of immunosuppression on the serum levels of Gd-IgA1, total IgA1 and IgA-IgG complexes in IgAN patients. In a retrospective study, serum samples from IgAN patients collected before transplantation (t(0)) and at 3- and 6-month posttransplant (t(3) & t(6)) were used to measure the levels of Gd-IgA1, total IgA1 and IgA-IgG complexes. The area under the curves (AUC) of immunosuppressants was calculated by the plot of plasma trough level or dosage of each immunosuppressant versus time and was interpreted as the extent of drug exposure. Thirty-six out of 64 IgAN patients, who underwent kidney transplantation between 2005 and 2012, were enrolled. From t(0) to t(3), serum Gd-IgA1 and total IgA1 decreased significantly (24.7 AU (18.6–36.1) to 17.2 (13.1–29.5) (p<0.0001); 4.1 mg/ml (3.6–5.1) to 3.4 (3.0–4.1) (p = 0.0005)), whereas IgA-IgG complexes remained similar. From t(3) to t(6), Gd-IgA1 and IgA-IgG complexes significantly increased (17.2 AU (13.1–29.5) to 23.9 (16.8–32.0) (p = 0.0143); OD 0.16 (0.06–0.31) to 0.26 (0.14–0.35) (p = 0.0242)), while total IgA1 remained similar. According to median regression analysis, AUC of prednisone t(0-6) was significantly associated with the decrease of Gd-IgA1 t(0-6) (P = 0.01) and IgA1 t(0-6) (p = 0.002), whereas AUC of tacrolimus t(0-6) was associated with the decrease of IgA1 t(0-6) (p = 0.02). AUC of prednisone t(0-3) was associated with the decrease of IgA-IgG complexes t(0)-(3) (p = 0.0036). The association of AUC prednisone t(0-6) with Gd-IgA1 t(0-6) remained highly significant after adjustment for other immunosuppressants (p = 0.0036). Serum levels of Gd-IgA1, total IgA1 and IgA-IgG in patients with IgAN vary according to the changing degrees of immunosuppression. The exposure to prednisone most clearly influenced the serum levels of Gd-IgA1.
format Online
Article
Text
id pubmed-5145158
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51451582016-12-22 Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy Kim, Min Jeong Schaub, Stefan Molyneux, Karen Koller, Michael T. Stampf, Susanne Barratt, Jonathan PLoS One Research Article Galactose-deficient IgA1 (Gd-IgA1) and IgA-IgG complexes are known to play an important role in the pathogenesis of IgA nephropathy (IgAN). We aimed therefore to determine the impact of immunosuppression on the serum levels of Gd-IgA1, total IgA1 and IgA-IgG complexes in IgAN patients. In a retrospective study, serum samples from IgAN patients collected before transplantation (t(0)) and at 3- and 6-month posttransplant (t(3) & t(6)) were used to measure the levels of Gd-IgA1, total IgA1 and IgA-IgG complexes. The area under the curves (AUC) of immunosuppressants was calculated by the plot of plasma trough level or dosage of each immunosuppressant versus time and was interpreted as the extent of drug exposure. Thirty-six out of 64 IgAN patients, who underwent kidney transplantation between 2005 and 2012, were enrolled. From t(0) to t(3), serum Gd-IgA1 and total IgA1 decreased significantly (24.7 AU (18.6–36.1) to 17.2 (13.1–29.5) (p<0.0001); 4.1 mg/ml (3.6–5.1) to 3.4 (3.0–4.1) (p = 0.0005)), whereas IgA-IgG complexes remained similar. From t(3) to t(6), Gd-IgA1 and IgA-IgG complexes significantly increased (17.2 AU (13.1–29.5) to 23.9 (16.8–32.0) (p = 0.0143); OD 0.16 (0.06–0.31) to 0.26 (0.14–0.35) (p = 0.0242)), while total IgA1 remained similar. According to median regression analysis, AUC of prednisone t(0-6) was significantly associated with the decrease of Gd-IgA1 t(0-6) (P = 0.01) and IgA1 t(0-6) (p = 0.002), whereas AUC of tacrolimus t(0-6) was associated with the decrease of IgA1 t(0-6) (p = 0.02). AUC of prednisone t(0-3) was associated with the decrease of IgA-IgG complexes t(0)-(3) (p = 0.0036). The association of AUC prednisone t(0-6) with Gd-IgA1 t(0-6) remained highly significant after adjustment for other immunosuppressants (p = 0.0036). Serum levels of Gd-IgA1, total IgA1 and IgA-IgG in patients with IgAN vary according to the changing degrees of immunosuppression. The exposure to prednisone most clearly influenced the serum levels of Gd-IgA1. Public Library of Science 2016-12-08 /pmc/articles/PMC5145158/ /pubmed/27930655 http://dx.doi.org/10.1371/journal.pone.0166830 Text en © 2016 Kim et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kim, Min Jeong
Schaub, Stefan
Molyneux, Karen
Koller, Michael T.
Stampf, Susanne
Barratt, Jonathan
Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title_full Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title_fullStr Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title_full_unstemmed Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title_short Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy
title_sort effect of immunosuppressive drugs on the changes of serum galactose-deficient iga1 in patients with iga nephropathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145158/
https://www.ncbi.nlm.nih.gov/pubmed/27930655
http://dx.doi.org/10.1371/journal.pone.0166830
work_keys_str_mv AT kimminjeong effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy
AT schaubstefan effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy
AT molyneuxkaren effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy
AT kollermichaelt effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy
AT stampfsusanne effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy
AT barrattjonathan effectofimmunosuppressivedrugsonthechangesofserumgalactosedeficientiga1inpatientswithiganephropathy